Brief: Glanbia raises FY EPS guidance, volumes up across all units year-to-date
BRIEF-Glanbia raises FY EPS guidance, volumes up across all units year-to-date Nov 4 (Reuters) - Glanbia PLC GL9.I:
GLANBIA - GROUP LIKE-FOR-LIKE REVENUE +9.9% FOR NINE MONTHS ENDED OCT 3 WITH VOLUME GROWTH ACROSS ALL THREE SEGMENTS
GLANBIA - Q3 OPTIMUM NUTRITION LFL REVENUE GROWTH OF 26.9% (+0.8% VOLUME; +26.1% PRICE)
GLANBIA - OPTIMUM NUTRITION REVENUE +25.8% YEAR-TO-DATE DRIVEN BY STRONG CATEGORY GROWTH, MARKET SHARE GAINS, NEW DISTRIBUTION, PRICING ACTIONS
GLANBIA - FY PERFORMANCE NUTRITION REVENUE GUIDANCE TO 16% TO 17% (PREVIOUSLY 12% TO 14%);
GLANBIA - RAISES FY GUIDANCE TO ADJUSTED EPS GROWTH OF 22% TO 24% CONSTANT CURRENCY (PREVIOUSLY 17% TO 20%).
GLANBIA - FY DAIRY NUTRITION EBITDA GUIDANCE TO $175-180 MILLION (PREVIOUSLY $170-180 MILLION); ALL OTHERS UNCHANGED
GLANBIA - PERFORMANCE NUTRITION REVENUE +18.0% YEAR-TO-DATE, HEALTH & NUTRITION REVENUE + 9.8%, DAIRY NUTRITION REVENUE +2.1%
GLANBIA - WENDY CHANG SMITH APPOINTED CFO DESIGNATE, EFFECTIVE AS CFO AND EXECUTIVE DIRECTOR FROM 31 MARCH 2027
GLANBIA - HEALTH & NUTRITION PRICING DECREASE WAS PREDOMINANTLY DRIVEN BY SOME TARIFF REFUNDS AND VOLUME REBATES TO CUSTOMERS
Further company coverage: GL9.I
(Reporting By Padraic Halpin)
((Padraic.Halpin@thomsonreuters.com;))
Recent news on Glanbia
See all newsBrief: Glanbia raises FY EPS guidance, volumes up across all units year-to-date
Third Quarter 2026 IMS
Proteinmaxxing is puny remedy for consumer giants
Europe Research Roundup: Amplifon, Continental, Tecan Group
Canada Research Roundup: Canadian National Railway, Intact Financial, Wellstar Technologies